---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-029353"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2025-09-18T23:59:59+00:00"
generated_at: "2026-05-17T06:19:24.028452+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioCardia prices $6M public offering of 4.8M shares and warrants; up to $6M more from warrant exercise

## Summary
- Public offering of 4,800,000 shares and short-term warrants for 4,800,000 shares at $1.25 per unit.
- Gross proceeds of $6 million upfront; potential additional $6 million if warrants fully exercised on cash basis.
- Short-term warrants exercisable at $1.25 per share, expire two years from issuance.
- Closing expected September 19, 2025; H.C. Wainwright acting as exclusive placement agent.
- Net proceeds to be used for working capital, advancing biotherapeutic candidates and delivery partnership business.

## SEC filing metadata
- accession: 0001437749-25-029353
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2025-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774925029353/0001437749-25-029353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774925029353/bcda20250918_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-029353
- JSON: https://secwatch.observer/filing/0001437749-25-029353.json
- Plain text: https://secwatch.observer/filing/0001437749-25-029353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.